According to ChemAnalyst the global Vitamin B12 Price has moved through a dramatic transformation over the past year, sliding through a prolonged bearish stretch across 2025 driven by oversupply and cautious procurement, before reversing sharply in March 2026 when Iranian conflict-driven energy costs and tightening distributor inventories pushed the U.S. market up by approximately 10%. As an essential water-soluble vitamin critical to red blood cell formation, DNA synthesis, and nervous system function, Vitamin B12, also known as cobalamin, occupies an indispensable position within the global pharmaceutical, nutraceutical, and dietary supplement supply chain, making the Vitamin B12 Trend Price a closely watched indicator for supplement manufacturers, pharmaceutical formulators, and procurement teams worldwide.
This report examines how Vitamin B12 pricing evolved across major global regions through 2025 and into the first quarter of 2026, the structural and geopolitical drivers behind these movements, and what the forecast suggests for the remainder of the year.
Overview of the Global Vitamin B12 Market
Vitamin B12, or cobalamin, is a water-soluble vitamin essential for the normal functioning of the brain and nervous system, for red blood cell formation, and for DNA synthesis and the metabolism of fatty acids and amino acids. Because the compound is primarily obtained through animal-based foods such as meat, fish, eggs, and dairy products, it is also widely used as a dietary supplement for individuals who are deficient or who have difficulty absorbing it through diet alone. Commercial Vitamin B12 production relies on fermentation-based synthesis processes, with cobalt serving as a key input given the vitamin's cobalt-containing molecular structure.
China stands as the leading global producer of Vitamin B12, while high consumption levels are concentrated in North America, Europe, and parts of Asia-Pacific, particularly in markets with strong dietary supplement and healthcare demand. On the demand side, pharmaceuticals, fortified foods, and dietary supplements represent the primary consuming applications, with clinical nutrition and anemia treatment applications adding further pharmaceutical-driven demand. Because Vitamin B12 addresses a genuinely essential nutritional need, and given rising global prevalence of B12 deficiency linked to poor dietary habits and malabsorption conditions, underlying demand has remained structurally resilient even as pricing has moved through considerable volatility over the past several years.
Regional Vitamin B12 Price Trend: The 2025 Bearish Cycle
March 2025: A Widespread Correction Takes Hold
Vitamin B12 prices declined moderately but consistently during March 2025, with cuts recorded across major exporting and importing destinations. Prices dipped between 0.5% and 1% in top world markets including the United States, China, India, and Germany, a seemingly modest percentage that nonetheless translated into a significant monetary movement given Vitamin B12's characteristically high price tag. This widespread correction reflected a combination of related market forces working simultaneously across the global supply chain, setting the tone for what would prove to be an extended bearish stretch through much of the year.
Q2 2025: Normalized Procurement and Tariff-Related Caution
The Vitamin B12 Spot Price Index in North America stood at approximately USD 1,463,000 per metric ton by the end of June 2025, reflecting a 0.34% dip driven by normalized pharmaceutical procurement and strategic inventory positioning. Steady imports from China and India continued without any supply chain disruptions during the quarter, allowing downstream users to maintain operational stocks and keeping the broader Vitamin B12 Production Cost Trend neutral. Downstream procurement across pharmaceuticals, fortified foods, and dietary supplements remained consistent, though buyers limited purchases to operational needs due to ongoing tariff-related caution, anchoring the demand outlook in a restrained posture throughout the quarter. Buyers refrained from speculative restocking during this period, preferring instead to draw down existing first-quarter inventory, a pattern that contributed to a broadly balanced but softening pricing environment.
Q3 2025: The Steepest Regional Decline
The Vitamin B12 Spot Price in North America declined further in July 2025 as subdued procurement behavior and balanced inventory levels persisted. A lack of new demand, combined with softened export offers from China, ensured no upward momentum in the price trend following the second quarter. This softness deepened considerably as the third quarter progressed, with North America ultimately experiencing the steepest quarterly fall of any major region, declining by 7.04% during the third quarter of 2025.
Europe, and Germany specifically, mirrored these global trends during the same period, with cautious buying behavior and ample availability weighing on regional price indices. Despite this broadly bearish tone across major markets, production costs remained largely unchanged throughout the period, limiting downside risks while simultaneously preventing any cost-driven price rebounds that might otherwise have offered support to the market.
The Turn Toward Late 2025: Signs of Mild Firmness
Despite the persistently bearish tone that had characterized much of 2025, the forward-looking Vitamin B12 price forecast issued around this time suggested mild firmness heading into late 2025 and early 2026, supported by selective restocking, seasonal production cycles, and stable demand from nutraceutical and feed premix sectors. However, upside potential was expected to remain limited given persistent oversupply, high inventory buffers, and generally stable production economics across the industry.
December 2025: Year-End Inventory Recalibration
The U.S. import market of Vitamin B12 saw prices increase during the final month of 2025, a shift in procurement behavior as buyers began purchasing for early new-quarter production runs. This period marked a recalibration for downstream manufacturers, who reassessed their inventory positions following the earlier decline recorded in November. Consistent demand from nutraceutical, fortified food, and pharmaceutical end-users kept procurement volumes steady throughout December, with firm procurement activity reducing spot availability in the import market and pushing prices modestly higher. This improved market sentiment was supported by coordinated buying activity and disciplined supplier response, with the December dynamics shaped more by inventory management ahead of uninterrupted early-2026 production schedules than by any speculative demand surge.
Track Real Time Prices Of Vitamin B12
https://www.chemanalyst.com/ChemAnalyst/PricingForm?Product=Vitamin%20B12
The Sharp Reversal: March 2026
Geopolitical Tensions Drive a Dramatic U.S. Price Surge
The U.S. Vitamin B12 market moved sharply higher through March 2026, a movement driven primarily by tight distributor inventories and disciplined seller offers that amplified spot activity into late-month procurement. Early March saw only modest adjustments, with routine trading and cautious seller behavior setting the initial tone for the month. However, a stronger mid-month rally was triggered by consistent spot transactions combined with escalating geopolitical tensions tied to the Iran conflict, which tightened prompt availability considerably. By late March, the market registered a pronounced upside move, ultimately surging by approximately 10%, reflecting a convergence of firm distributor demand, steady spot trading, and elevated energy awareness that encouraged importers to secure Vitamin B12 cargoes promptly.
Rising crude oil, LPG, and bunker fuel benchmarks lifted steam-generation and freight costs considerably, directly increasing landed costs for Vitamin B12 imports and related intermediates. Insurers and shippers began pricing war-risk premiums into routing decisions, prompting some importers to accelerate their Vitamin B12 purchases to hedge against potential future premium increases. This link between geopolitical risk and Vitamin B12 pricing heightened the U.S. market's sensitivity to conflict escalation and any developments that could pressure transport and insurance markets further. Weekly patterns through late March showed stepwise increases in pricing as spot buying intensified, with market participants generally interpreting these moves as a distributor-led rerating of prompt availability rather than any structural supply collapse. Notably, an ample cobalt supply backdrop for Vitamin B12 production provided a moderating influence, helping cap the extent of the surge even amid the broader energy-driven cost pressure.
Key Drivers Behind the Vitamin B12 Trend Price in 2026
1. Geopolitical Disruptions and Energy Costs — The Iranian conflict's impact on crude oil, LPG, and bunker fuel benchmarks has directly elevated freight, insurance, and steam-generation costs, representing the single most significant driver of the sharp March 2026 U.S. price surge.
2. Distributor Inventory Positioning — Tight distributor inventories and disciplined seller offers amplified spot market activity considerably during the March 2026 rally, illustrating how inventory positioning can drive pricing independent of any underlying supply disruption.
3. Cobalt Supply Conditions — Given cobalt's role as a key input for Vitamin B12's fermentation-based production process, ample global cobalt availability has provided an important moderating influence, helping limit the extent of cost-driven price increases even amid broader energy market pressure.
4. Chinese Export Offers and Production Conditions — As the leading global producer, Chinese export pricing and production conditions continue to represent a central determinant of global Vitamin B12 availability and cost benchmarks.
5. Oversupply and Inventory Buffers — The persistent oversupply and high inventory buffers that characterized much of 2025 continue to represent an important structural factor limiting the market's near-term upside potential, even amid periods of geopolitically driven price pressure.
6. Nutraceutical and Pharmaceutical Demand — Consistent demand from dietary supplement manufacturers, fortified food producers, and pharmaceutical formulators addressing clinical nutrition and anemia treatment needs continues to provide a resilient underlying demand base.
7. War-Risk Insurance and Shipping Premiums — Insurers and shippers pricing war-risk into routing decisions during periods of geopolitical escalation has added a further, often underappreciated layer of cost pressure affecting landed Vitamin B12 import costs.
Vitamin B12 Price Forecast: Outlook for 2026
Looking ahead, ChemAnalyst expects a firm but range-bound increase in the Vitamin B12 market in the near term, contingent on importers continuing their strategic stock-building activity and energy-linked premiums persisting amid ongoing geopolitical uncertainty. The ample cobalt backdrop for Vitamin B12 production is expected to continue providing a moderating influence on pricing, helping prevent the kind of unchecked escalation that might otherwise occur during periods of acute energy market stress.
Longer-term structural growth for the broader Vitamin B12 market remains solidly positive, though estimates vary depending on methodology and scope. Industry projections point to a global market value of approximately USD 216.8 million in 2025, growing to roughly USD 230 million in 2026 and reaching USD 406 million by 2034, reflecting a compound annual growth rate of approximately 7.40%. Asia-Pacific dominated the global market with a substantial majority share in 2025, reflecting the region's expanding dietary supplement consumption and rising healthcare awareness. This growth trajectory is expected to be driven by the increasing prevalence of Vitamin B12 deficiency, rising awareness about the importance of dietary supplements, and growing preference for preventive healthcare approaches among consumers worldwide.
For procurement and sourcing teams, key variables to monitor through the remainder of 2026 include the trajectory of Iranian conflict-related geopolitical tensions and their impact on energy and shipping costs, Chinese export pricing and production trends, cobalt market conditions, and distributor inventory positioning across major consuming regions. Each of these factors will play a meaningful role in determining whether the Vitamin B12 Trend Price sustains its March 2026 firming or reverts toward the oversupply-driven softness that characterized much of the prior year.
Conclusion
The global Vitamin B12 Price trend has undergone a dramatic transformation, moving from a prolonged bearish cycle through 2025, marked by oversupply, cautious procurement, and North America's steepest-ever 7.04% quarterly decline, into a sharp reversal in March 2026 when Iranian conflict-driven energy costs and tight distributor inventories pushed U.S. pricing up by approximately 10%. With cobalt supply conditions providing an important moderating counterweight to energy-driven cost pressure, and with strong long-term structural demand expected from rising B12 deficiency prevalence and expanding dietary supplement consumption, the Vitamin B12 Trend Price is likely to remain sensitive to geopolitical developments and distributor inventory behavior through much of 2026, making close monitoring of these factors essential for supplement manufacturers, pharmaceutical formulators, and procurement teams alike.
Contact -
Address:
420 Lexington Avenue, Suite 300
New York, NY 10170
United States
Phone: +1 332 258 6602
Website: www.chemanalyst.com
LinkedIn: https://www.linkedin.com/company/chemanalyst/
X (Twitter): https://x.com/chemanalysts
Facebook: https://www.facebook.com/ChemAnalysts/
.png)
0 Comments